The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Article in Hemato (August 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Hemato (August 2024)
Article in Scientific Reports (February 2024)
Article in International Journal of Molecular Sciences (December 2023)